Name
osaühing TorroSen
Registry code
10563572
VAT number
EE100578416
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.06.1999 (25)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
72111 - Research and experimental development on biotechnology
67 898 €
23 764 €
35%
2 108 €
(estimate is approximate)
206 964 €
1
Submitted
No tax arrears
11%
11%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ago Rinken 13.06.1960 (64) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| Toonika Rinken 13.11.1962 (62) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| KemInvent OÜ 12771636 | - | - | - | Founder |
| ToxInvent OÜ 12805625 | - | - | - | Founder |
| 2019 22.06.2020 | 2020 22.06.2021 | 2021 20.06.2022 | 2022 29.06.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 32 716 € | 64 216 € | 41 642 € | 56 874 € | 67 898 € |
| Net profit (loss) for the period | -1 550 € | -47 580 € | -4 514 € | 20 879 € | 23 764 € |
| Profit Margin | -5% | -74% | -11% | 37% | 35% |
| Current Assets | 215 799 € | 170 915 € | 157 222 € | 172 859 € | 183 529 € |
| Fixed Assets | 2 252 € | 6 867 € | 11 537 € | 19 026 € | 27 620 € |
| Total Assets | 218 051 € | 177 782 € | 168 759 € | 191 885 € | 211 149 € |
| Current Liabilities | 3 637 € | 10 948 € | 6 439 € | 8 686 € | 4 185 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 214 414 € | 166 834 € | 162 320 € | 183 199 € | 206 964 € |
| Employees | 2 | 3 | 2 | 2 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 2 091.2 € | 2 267.2 € | - |
| 2023 Q4 | 14 049 € | 5 843.06 € | 3 593.52 € | 1 |
| 2023 Q3 | 14 710.81 € | 5 619.97 € | 3 509.5 € | 2 |
| 2023 Q2 | 16 864.18 € | 6 152.97 € | 3 331.9 € | 2 |
| 2023 Q1 | 31 090.95 € | 6 563.71 € | 3 689.88 € | 2 |
| 2022 Q4 | 17 632.4 € | 3 981.25 € | 1 991.27 € | 2 |
| 2022 Q3 | 12 678.72 € | 5 911.89 € | 4 362.22 € | 3 |
| 2022 Q2 | - | - | - | 2 |
| 2022 Q1 | 18 196.45 € | 8 080.53 € | 4 874.48 € | 2 |
| 2021 Q4 | - | 2 248.04 € | 2 437.24 € | 2 |
| 2021 Q3 | 17 192.7 € | 7 715.03 € | 4 651.02 € | 2 |
| 2021 Q2 | 451 € | 2 248.04 € | 2 437.24 € | 2 |
| 2021 Q1 | 44 409.55 € | 13 313.65 € | 7 110.42 € | 3 |
| 2020 Q4 | 728 € | 2 870.67 € | 3 142.64 € | 3 |
| 2020 Q3 | 20 014.7 € | 6 634.2 € | 4 471.21 € | 4 |
| 2020 Q2 | - | 2 409.17 € | 2 635.49 € | 3 |
| 2020 Q1 | 24 645 € | 8 337.4 € | 4 283.76 € | 3 |
